Is r-directpa safe to use?

r-directpa has no known vulnerabilities on the latest version (1.5.1). DepScope rates its health at 43/100 (high risk).

What is the latest version of r-directpa?

The latest version of r-directpa is 1.5.1, released 2025-09-23.

Does r-directpa have known vulnerabilities?

No known vulnerabilities on the latest version of r-directpa.

Is r-directpa deprecated?

No, r-directpa is actively maintained. Latest release: 1.5.1 (2025-09-23).

What are alternatives to r-directpa?

DepScope has no curated alternatives for r-directpa at this time.

What license does r-directpa use?

r-directpa is licensed under GPL-3.0-or-later.

r-directpa

condav1.5.1

Direction analysis is a set of tools designed to identify combinatorial effects of multiple treatments/conditions on pathways and kinases profiled by microarray, RNA-seq, proteomics, or phosphoproteomics data. See Yang P et al (2014) <doi:10.1093/bioinformatics/btt616>; and Yang P et al. (2016) <doi:10.1002/pmic.201600068>.

License GPL-3.0-or-later2 versions1 maintainers0 deps79 weekly dl

/ 100

Health

use with caution

[email protected] low health (43/100) — consider alternatives

Moderate health score (43/100) — verify manually

Health breakdown0 – 100

10/25

maintenance

0/20

popularity

25/25

security

6/15

maturity

2/15

community

Vulnerabilities

none known

Health History

Dependency Tree

License Audit

API access

Get this data programmatically — free, no authentication.

curl https://depscope.dev/api/check/conda/r-directpa

First published · 2023-07-19 22:22:28.101000+00:00

Last updated · 2025-09-23 19:38:41.072000+00:00